phosphorylethanolamine has been researched along with Canine Diseases in 2 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alisauskaite, N | 1 |
Beckmann, K | 1 |
Dennler, M | 1 |
Zölch, N | 1 |
Kyöstilä, K | 1 |
Syrjä, P | 1 |
Lappalainen, AK | 1 |
Arumilli, M | 1 |
Hundi, S | 1 |
Karkamo, V | 1 |
Viitmaa, R | 1 |
Hytönen, MK | 1 |
Lohi, H | 1 |
2 other studies available for phosphorylethanolamine and Canine Diseases
Article | Year |
---|---|
Brain proton magnetic resonance spectroscopy findings in a Beagle dog with genetically confirmed Lafora disease.
Topics: Animals; Aspartic Acid; Brain; Choline; Dog Diseases; Dogs; Ethanolamines; Female; Glutamic Acid; Gl | 2020 |
A homozygous missense variant in the alkaline phosphatase gene ALPL is associated with a severe form of canine hypophosphatasia.
Topics: Alkaline Phosphatase; Amino Acid Sequence; Animals; Breeding; Calcification, Physiologic; Conserved | 2019 |